Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,830 | -11,406 | N/A |
| Depreciation Amortization | 498 | 274 | N/A |
| Accounts payable and accrued liabilities | 804 | 570 | N/A |
| Other Working Capital | 17,526 | 50 | N/A |
| Other Operating Activity | -284 | -282 | 0 |
| Operating Cash Flow | $1,714 | $-10,794 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2,275 | -553 | N/A |
| Other Investing Activity | 6,750 | 0 | 0 |
| Investing Cash Flow | $4,475 | $-553 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 2,496 | 2,478 | N/A |
| Common Stock Issued | 22 | 81 | N/A |
| Other Financing Activity | 19,731 | 7,426 | 0 |
| Financing Cash Flow | $22,249 | $9,985 | $N/A |
| Beginning Cash Position | 985 | 2,347 | N/A |
| End Cash Position | 29,423 | 985 | N/A |
| Net Cash Flow | $28,438 | $-1,362 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 1,714 | -10,794 | N/A |
| Capital Expenditure | -2,275 | -553 | N/A |
| Free Cash Flow | -561 | -11,347 | 0 |